Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for Acadia Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (ACAD).
- Disclosed ownership: 5.2%.
- Date of event: 31 Dec 2024.
RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Acadia Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (ACAD)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- ACAD
- Shares outstanding
- 167,413,481 shares
- Disclosed Ownership
- 8,705,501 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 09:00:06 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 5.2% ownership in Acadia Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (ACAD) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 09:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 5.2% | 8,705,501 | 0 | 8,705,501 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong, M.D. | 5.2% | 8,705,501 | 0 | 8,705,501 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D. |